CHEMICO-BIOLOGICAL INTERACTIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-09-15 zj9032

偏重的研究方向：毒理学
经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2024-02-11 ms3000000318731306

从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。

23 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-05-07 ms8000000052642773 来自山东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：毒理;细胞毒性
经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。

45 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-09-11 ms5000001598335110 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：抗肿瘤
经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-08-14 ms3000000642729823 来自浙江省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：药理学
经验分享：审稿人的问题要好好回答

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-07-19 ms3000000642729823 来自浙江省

偏重的研究方向：药理学
经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-07-16 ms5000001598335110 来自湖南省

审稿速度:2.0
偏重的研究方向：抗肿瘤
经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-03-19 ms6000001826149369 来自湖南省

请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-04-19 zj9032 来自江西省

审稿速度:1.0
偏重的研究方向：毒理
经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2157836, encodeId=32f2215e83692, content=偏重的研究方向：毒理学 经验分享：5月底投的，9月初接收，一共修了三次，除了第一次审稿花的时间较长有一个多月，后面两次都在半个月左右外审结束。补了很多很多实验。体感就是一定要认真答复，一条条仔仔细细引用文献或者补实验去回答。ps中途遇到track系统突然无法检索投稿文章进度，差点吓死。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Fri Sep 15 14:41:43 CST 2023, time=2023-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186909, encodeId=82ed2186909f3, content=从23年12月15号投，很快under review。然后24年2月8号发邮件说找不到审稿人，拒了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bd15519070, createdName=ms3000000318731306, createdTime=Sun Feb 11 15:41:19 CST 2024, time=2024-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130708, encodeId=34ca2130e0886, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：毒理;细胞毒性 经验分享：投稿到接收两个月的时间，挺快的，只要按照审稿人的意见认真修改基本就没啥问题。原始数据没有强制要求，不过审稿人提出来需要将原始数据作为补充文件提交。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44495440819, createdName=ms8000000052642773, createdTime=Sun May 07 08:49:28 CST 2023, time=2023-05-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157089, encodeId=5cc5215e0897e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗肿瘤 经验分享：4月份投稿，8月份接收，中途经历过换审稿人。觉得期刊编辑比较nice，期刊比较严谨、负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Mon Sep 11 09:49:56 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2152691, encodeId=3cb921526910d, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：审稿人的问题要好好回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Mon Aug 14 14:20:14 CST 2023, time=2023-08-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148755, encodeId=9c6f2148e553b, content=偏重的研究方向：药理学 经验分享：初审6个月，审稿人给出大修，然后二审已经3个月还没有消息，怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db18188502, createdName=ms3000000642729823, createdTime=Wed Jul 19 10:49:14 CST 2023, time=2023-07-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2148281, encodeId=a5e9214828124, content=审稿速度:2.0 偏重的研究方向：抗肿瘤 经验分享：二审一个多月了，纠结要不要催一下稿。。。但是好怕被拒呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Sun Jul 16 14:38:08 CST 2023, time=2023-07-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2120453, encodeId=4dfc2120453c2, content=请问大家有这个杂志的投稿须知吗？官网上的链接一直打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3858365928, createdName=ms6000001826149369, createdTime=Sun Mar 19 18:17:09 CST 2023, time=2023-03-19, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2126944, encodeId=d9952126944f2, content=审稿速度:1.0 偏重的研究方向：毒理 经验分享：编辑友好，审稿周期长，主要时间都是花在是审稿人那边，认真答就行。wb原图杂志没有要求，最后一次审稿遇到的审稿人要求提供原图，就交了一次的图。如果没有审稿人提，应该不需要投稿时提供, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32602625368, createdName=zj9032, createdTime=Wed Apr 19 07:14:28 CST 2023, time=2023-04-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2117185, encodeId=b87b211e185d8, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：天然产物;抗肿瘤 经验分享：Under Review 一个月后，最好发邮件问一下状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2b98377264, createdName=ms5000000504492338, createdTime=Thu Mar 02 10:02:59 CST 2023, time=2023-03-02, status=1, ipAttribution=重庆)]

2023-03-02 ms5000000504492338 来自重庆

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：天然产物;抗肿瘤
经验分享：Under Review 一个月后，最好发邮件问一下状态

45 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务